The first company to attempt to cheaply sequence the genomes of 100 people aged over 100 announced its intention to compete for the 2013 X prize.
The first company to attempt to cheaply sequence the genomes of 100 people aged over 100 announced its intention to compete for the 2013 X prize.
Why naked mole-rats and experimental gene therapies remind me of groundbreaking artists.
Page 1 of 1